These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 15834715)

  • 1. Animal cell cultures: recent achievements and perspectives in the production of biopharmaceuticals.
    Butler M
    Appl Microbiol Biotechnol; 2005 Aug; 68(3):283-91. PubMed ID: 15834715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guidelines to cell engineering for monoclonal antibody production.
    Rita Costa A; Elisa Rodrigues M; Henriques M; Azeredo J; Oliveira R
    Eur J Pharm Biopharm; 2010 Feb; 74(2):127-38. PubMed ID: 19853660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion of a CHO cell culture process from perfusion to fed-batch technology without altering product quality.
    Meuwly F; Weber U; Ziegler T; Gervais A; Mastrangeli R; Crisci C; Rossi M; Bernard A; von Stockar U; Kadouri A
    J Biotechnol; 2006 May; 123(1):106-16. PubMed ID: 16324762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioreactor systems for the production of biopharmaceuticals from animal cells.
    Warnock JN; Al-Rubeai M
    Biotechnol Appl Biochem; 2006 Jul; 45(Pt 1):1-12. PubMed ID: 16764553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Derivation and characterization of cholesterol-independent non-GS NS0 cell lines for production of recombinant antibodies.
    Hartman TE; Sar N; Genereux K; Barritt DS; He Y; Burky JE; Wesson MC; Tso JY; Tsurushita N; Zhou W; Sauer PW
    Biotechnol Bioeng; 2007 Feb; 96(2):294-306. PubMed ID: 16897745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining process design space for monoclonal antibody cell culture.
    Abu-Absi SF; Yang L; Thompson P; Jiang C; Kandula S; Schilling B; Shukla AA
    Biotechnol Bioeng; 2010 Aug; 106(6):894-905. PubMed ID: 20589669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering mammalian cells in bioprocessing - current achievements and future perspectives.
    Lim Y; Wong NS; Lee YY; Ku SC; Wong DC; Yap MG
    Biotechnol Appl Biochem; 2010 Apr; 55(4):175-89. PubMed ID: 20392202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In pursuit of the optimal fed-batch process for monoclonal antibody production.
    Bibila TA; Robinson DK
    Biotechnol Prog; 1995; 11(1):1-13. PubMed ID: 7765983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions.
    Rourou S; van der Ark A; van der Velden T; Kallel H
    Vaccine; 2007 May; 25(19):3879-89. PubMed ID: 17307281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defined protein-free NS0 myeloma cell cultures: stimulation of proliferation by conditioned medium factors.
    Spens E; Häggström L
    Biotechnol Prog; 2005; 21(1):87-95. PubMed ID: 15903244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of culture environment for improved polyethylenimine-mediated transient production of recombinant monoclonal antibodies by CHO cells.
    Galbraith DJ; Tait AS; Racher AJ; Birch JR; James DC
    Biotechnol Prog; 2006; 22(3):753-62. PubMed ID: 16739959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Process control in cell culture technology using dielectric spectroscopy.
    Justice C; Brix A; Freimark D; Kraume M; Pfromm P; Eichenmueller B; Czermak P
    Biotechnol Adv; 2011; 29(4):391-401. PubMed ID: 21419837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microarray-based gene expression analysis as a process characterization tool to establish comparability of complex biological products: scale-up of a whole-cell immunotherapy product.
    Wang M; Senger RS; Paredes C; Banik GG; Lin A; Papoutsakis ET
    Biotechnol Bioeng; 2009 Nov; 104(4):796-808. PubMed ID: 19591186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single-use purification process for the production of a monoclonal antibody produced in a PER.C6 human cell line.
    Kuczewski M; Schirmer E; Lain B; Zarbis-Papastoitsis G
    Biotechnol J; 2011 Jan; 6(1):56-65. PubMed ID: 21170980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Getting higher yields of monoclonal antibody in culture.
    Kundu PK; Prasad NS; Electricwala SE; Varma R; Datta D
    Indian J Physiol Pharmacol; 1998 Apr; 42(2):155-71. PubMed ID: 10225044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody production.
    Birch JR; Racher AJ
    Adv Drug Deliv Rev; 2006 Aug; 58(5-6):671-85. PubMed ID: 16822577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Manufacture of pharmaceutical proteins from hybridomas and other cell substrates.
    Tolbert WR; Rupp RG
    Dev Biol Stand; 1989; 70():49-56. PubMed ID: 2503410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein-free fed-batch culture of non-GS NS0 cell lines for production of recombinant antibodies.
    Burky JE; Wesson MC; Young A; Farnsworth S; Dionne B; Zhu Y; Hartman TE; Qu L; Zhou W; Sauer PW
    Biotechnol Bioeng; 2007 Feb; 96(2):281-93. PubMed ID: 16933323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of serum-free media for cell growth and production of viruses/viral vaccines--safety issues of animal products used in serum-free media.
    Merten OW
    Dev Biol (Basel); 2002; 111():233-57. PubMed ID: 12678248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.